Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice

被引:43
|
作者
Fazio, S [1 ]
Babaev, VR
Burleigh, ME
Major, AS
Hasty, AH
Linton, MF
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA
关键词
apolipoprotein E; low density lipoprotein receptor; hyperlipidemia; bone marrow transplant;
D O I
10.1194/jlr.M200108-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously reported that the introduction of macrophage apoE into mice lacking both apoE and the LDL receptor (apoE(-/-)/LDLR-/-) through bone marrow transplantation (apoE(+/+)/LDLR-/--->apoE(-/-)/LDLR-/-) produces progressive accumulation of apoE in plasma without affecting lipid levels. This model provides a tool to study the effects of physiologically regulated amounts of macrophage apoE on atherogenesis in hyperlipidemic animals. Ten-week-old male apoE(-/-)/LDLR-/- mice were transplanted, with either apoE(+/+)/LDLR-/- (n=11) or apoE(-/-)/LDLR-/- (n=14) marrow. Although there were no differences between the two groups in lipid levels at baseline or at 5 and 9 weeks after transplantation, apoE levels in the apoE(+/+)LDLR(-/-)-->apoE(-/-)/LDLR-/- mice increased to 4 times the apoE levels of normal mice. This resulted in a 60% decrease in aortic atherosclerosis in the apoE(+/+)/LDLR-/--->apoE(-/-)/LDLR-/- compared with the apoE(-/-)/LDLR-/--->apoE(-/-)/LDLR-/- controls, (15,957 +/- 1907 vs. 40,115 +/- 8302 mum(2) +/- SEM, respectively). In a separate experiment, apoE(+/+)/LDLR-/- mice were transplanted with either apoE(+/+)/LDLR-/- or apoE(-/-)/LDLR-/- marrow and placed on a high-fat diet for 8 weeks. In the absence of macrophage apoE, lesion area was increased by 75% in the aortic sinus and by 56% in the distal aorta. These data show that physiologic levels of macrophage apoE in the vessel wall are anti-atherogenic in conditions of severe hyperlipidemia and can affect later stages of plaque development.-Fazio, S., V R_ Babaev, M. E, Burleigh, A. S. Major, A. H. Hasty, and M. F. Linton. Physiologic expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice.
引用
收藏
页码:1602 / 1609
页数:8
相关论文
共 50 条
  • [21] A synthetic promoter drives macrophage expression of ApoE and ameliorates atherosclerosis
    Li, SL
    He, WJ
    Qiang, M
    Wang, W
    Xiao, QF
    Valente, AJ
    Quinones, M
    Ahuja, S
    Clark, RA
    Freeman, GL
    JOURNAL OF LEUKOCYTE BIOLOGY, 2004, : 55 - 56
  • [22] Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice
    Tennert, Carsten
    Teupser, Daniel
    Mueller, Marc A.
    Wilfert, Wolfgang
    Renner-Mueller, Ingrid
    Stein, Olga
    Stein, YechezkIel
    Sippel, Albrecht E.
    Wolf, Eckhard
    Thiery, Joachim
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 361 (03) : 574 - 579
  • [23] A novel endothelial nitric oxide synthase expression enhancer reduces atherosclerosis in apoE-deficient mice
    Wohlfart, P
    Tiemann, M
    Strobel, H
    Suzuki, T
    Dharanipragada, R
    Li, H
    Foerstermann, U
    Ruetten, H
    CIRCULATION, 2002, 106 (19) : 213 - 213
  • [24] Impavido attenuates inflammation, reduces atherosclerosis, and alters gut microbiota in hyperlipidemic mice
    Traughber, C. Alicia
    Iacano, Amanda J.
    Neupane, Kalash
    Khan, Mariam R.
    Opoku, Emmanuel
    Nunn, Tina
    Prince, Ashutosh
    Sangwan, Naseer
    Hazen, Stanley L.
    Smith, Jonathan D.
    Gulshan, Kailash
    ISCIENCE, 2023, 26 (04)
  • [25] TRIF Deficiency Reduces Atherosclerosis in Hyperlipidemic LDL-Receptor Knockout Mice
    Richards, M. Rachel
    Black, Audrey S.
    Bonnet, David J.
    McKeon, Karen K.
    Barish, Grant D.
    Hoebe, Kasper H.
    Tobias, Peter T.
    Curtiss, Linda K.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E295 - E295
  • [26] Adenine-Induced Nephropathy Reduces Atherosclerosis in ApoE Knockout Mice
    Scherler, Laeticia
    Verouti, Sofia
    Ackermann, Daniel
    Vogt, Bruno
    Escher, Genevieve
    SWISS MEDICAL WEEKLY, 2022, 152 : 31S - 31S
  • [27] Adenine-Induced Nephropathy Reduces Atherosclerosis in ApoE Knockout Mice
    Scherler, Laeticia
    Verouti, Sofia N.
    Ackermann, Daniel
    Vogt, Bruno
    Escher, Genevieve
    BIOMOLECULES, 2022, 12 (08)
  • [28] BAFF Receptor mAb Treatment Ameliorates Development and Progression of Atherosclerosis in Hyperlipidemic ApoE-/- Mice
    Kyaw, Tin
    Cui, Peng
    Tay, Christopher
    Kanellakis, Peter
    Hosseini, Hamid
    Liu, Edgar
    Rolink, Antonius G.
    Tipping, Peter
    Bobik, Alex
    Toh, Ban-Hock
    PLOS ONE, 2013, 8 (04):
  • [29] Loss of Inhibitory Fcgamma Receptor II is not Sufficient to Promote Atherosclerosis in Hyperlipidemic Apoe Knockout Mice
    Zhu, Xinmei
    Ng, Hangpong
    Nagarajan, Shanmugam
    CIRCULATION, 2013, 128 (22)
  • [30] Macrophage-specific expression of human apoAI protects against atherosclerosis in apoE-deficient mice.
    Major, AS
    Brown, AM
    Ishiguro, H
    Linton, MF
    Fazio, S
    CIRCULATION, 2000, 102 (18) : 315 - 315